Regulatory News
Monday, May 2, 2016
BRIEF-Eisai says FDA approves oral suspension version of epilepsy drug, Fycompa
May 2 (Reuters) - Eisai Announces FDA Approval Of Fycompa
(Perampanel) Oral Suspension For Adjunctive Therapy In The
Treatment Of Partial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment